Rapid Education on COVID-19 Outpatient Treatment

Concept of SACS CoV2 or Coronavirus Stock Photo

During the COVID-19 pandemic, major breakthroughs have been made on the identifications of viral strains/RNA sequences, viral receptors, and their partners, as well as development of effective vaccines.

Importantly, molecular mechanisms underlying the pathogenesis of COVID-19 are far from being fully understood. Since SARS-CoV-2 receptor angiotensin converting enzyme 2 (ACE2) is highly expressed in the cardiovascular system, and that organ failure of the heart and lungs represents major pathological features of COVID-19, it is important to familiarize healthcare professionals with the latest progress on the phenotypes and mechanisms of systemic injuries during the pathogenesis of COVID-19 to facilitate deploying appropriate therapeutic treatment.1

Digital Learning Activities

Digital Learning Activities have emerged as an increasingly effective tool for CE and knowledge dissemination. The Digital Learning Activities offer the learner threaded bits of instruction on a specific topic in an easily consumable format. A better-informed healthcare workforce contributes to improved patient outcomes. Earn 0.5 CE credits per Digital Learning Activity.

Guidelines and Articles

COVID-19 and Cardiovascular Disease | Circulation Research (ahajournals.org)
Chung MK, Zidar DA, Bristow MR, et al. COVID-19 and cardiovascular disease. Circulation Research. 2021; 128:1214-1236 doi.org/10.1161/CIRCRESAHA.121.317997

Viruses | Free Full-Text | Impact of COVID-19 on Cardiovascular Disease (mdpi.com)
Vosko I, Zirlik A, Bugger H. Impact of COVID-19 on Cardiovascular Disease. Viruses. 2023 Feb 11;15(2):508. doi: 10.3390/v15020508. PMID: 36851722; PMCID: PMC9962056.

Racial and Ethnic Disparities in Heart and Cerebrovascular Disease Deaths During the COVID-19 Pandemic in the United States | Circulation (ahajournals.org)
Wadhera RK, Figueroa JF, Rodriguez F, et al. Racial and Ethnic Disparities in Heart and Cerebrovascular Disease Deaths During the COVID-19 Pandemic in the United States. Circulation. 2021 Jun 15;143(24):2346-2354. doi: 10.1161/CIRCULATIONAHA.121.054378.

References

1. Trougakos IP, Stamatelopoulos K, Terpos E, et al. Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications. J Biomed Sci 28, 9 (2021). https://doi.org/10.1186/s12929-020-00703-5.c.

This program is supported by a medical educational grant from grant from Pfizer.